Publications by authors named "Anja Kovanda"

Determining the genetic contribution of susceptibility to severe SARS-CoV-2 infection outcomes is important for public health measures and individualized treatment. Through intense research on this topic, several hundred genes have been implicated as possibly contributing to the severe infection phenotype(s); however, the findings are complex and appear to be population-dependent. We aimed to determine the contribution of human rare genetic variants associated with a severe outcome of SARS-CoV-2 infections and their burden in the Slovenian population.

View Article and Find Full Text PDF

Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS) is caused by biallelic pathogenic expansions, or compound heterozygosity with other pathogenic variants in the RFC1 gene. CANVAS is estimated to be underdiagnosed, both because of the lack of formal diagnostic criteria and molecular challenges that translate to lesser access and high cost of routine testing. Our aim was to address the need for making CANVAS genetic testing routine, by designing a streamlined two-step PCR consisting of a short-allele screening PCR and a confirmatory PCR with fragment capillary electrophoresis detection.

View Article and Find Full Text PDF

Parkinson's disease is a neurological disorder that affects motor function, autonomic functions, and cognitive abilities. It is likely that both genetic and environmental factors, along with age, contribute to the cause. However, there is no comprehensive guideline for genetic testing for Parkinson's disease, and more research is needed to understand genetic variations in different populations.

View Article and Find Full Text PDF

Facioscapulohumeral muscular dystrophy (FSHD) is the third most common hereditary muscular dystrophy, caused by the contraction of the D4Z4 repeats on the permissive 4qA haplotype on chromosome 4, resulting in the faulty expression of the gene. Traditional diagnostics are based on Southern blotting, a time- and effort-intensive method that can be affected by single nucleotide variants (SNV) and copy number variants (CNV), as well as by the similarity of the D4Z4 repeats located on chromosome 10. We aimed to evaluate optical genome mapping (OGM) as an alternative molecular diagnostic method for the detection of FSHD.

View Article and Find Full Text PDF

Background: The etiology of preterm birth (PTB) is heterogeneous and not yet well known. Maternal periodontal disease has been investigated for decades and is a known risk factor for adverse pregnancy outcomes. However, no particular bacterial species or higher taxonomic order has been found as causative of PTB, leading to studies of the whole oral microbiome.

View Article and Find Full Text PDF
Article Synopsis
  • Pathogenic genetic variants create complexities in prenatal counseling, particularly when the familial clinical presentation is unusual.
  • A case study highlighted the detection of an unusual inverted duplication causing X-linked Pelizaeus-Merzbacher disease, using advanced optical genome mapping technology.
  • The identification of this unique structural variant led to a successful reclassification and a healthy delivery, emphasizing the importance of novel techniques in understanding atypical genetic cases for better counseling.
View Article and Find Full Text PDF
Article Synopsis
  • Parkinson's disease (PD) is a neurodegenerative disorder with complex causes, and recent studies suggest that gut microbiota may play a role in its early development and symptom progression.
  • A systematic review of 20 selected studies (involving 1,511 PD patients) was conducted to evaluate the relationship between gut microbiota composition and PD symptoms.
  • The findings indicate a correlation between specific gut microbiota profiles and the severity of both motor and non-motor symptoms, highlighting the need for further research on how gut microbiota metabolism influences PD.
View Article and Find Full Text PDF
Article Synopsis
  • Parkinson's disease guidelines do not provide specific criteria for when genetic testing should be performed.
  • A study involving 149 early-onset and familial PD patients assessed the effectiveness of genetic testing through exome sequencing and gene panel analysis.
  • The findings suggest that genetic testing is beneficial for both early-onset and familial PD patients, with an expected clinical yield of around 10% in Caucasian populations.
View Article and Find Full Text PDF

Genomics is an advancing field of medicine, science, ethics, and legislation. Keeping up to date with this challenging discipline requires continuous education and exchange of knowledge between many target groups. Specific challenges in genomic education include tailoring complex topics to diverse audiences ranging from the general public and patients to highly educated professionals.

View Article and Find Full Text PDF
Article Synopsis
  • Many countries are studying the human genome to improve medical tests and treatments, which could lead to better health care for everyone.
  • There are 41 different national projects focusing on understanding normal and abnormal genes, with a goal to create personalized medicine that fits each person's needs.
  • A lot of these projects share data with researchers and have different funding sources, showing a wide range of approaches and plans for the future of health care.
View Article and Find Full Text PDF

Primary microcephalies (MCPH) are characterized by microcephaly (HC -2 SD at birth) in the absence of visceral malformations. To date, less than 20 genes have been associated with MCHP, several of which are involved in the formation and function of the centrosome. Here, we report a novel missense variant in the TUBGCP5 gene in a patient with primary microcephaly and mild developmental delay.

View Article and Find Full Text PDF
Article Synopsis
  • Epigenetic mechanisms, particularly DNA methylation, might influence when Huntington's disease (HD) symptoms appear, as shown by research on brain tissue and model organisms.*
  • This study investigated DNA methylation patterns in blood samples from symptomatic and pre-symptomatic HD patients and healthy controls to see if there are noticeable differences.*
  • While the researchers found 437 differentially methylated genes in pre-symptomatic HD patients, the findings indicate that blood methylation changes are not strong enough to be used as reliable biomarkers for predicting HD progression, suggesting more research is needed. *
View Article and Find Full Text PDF

Huntington's disease (HD) is a severe neurodegenerative disorder manifesting as progressive impairment of motor function, cognitive decline, psychiatric symptoms, and immunological and endocrine dysfunction. We explored the consistency of blood transcriptomic biomarkers in HD based on a novel Slovene patient cohort and expert review of previous studies. HumanHT-12 v4 BeadChip microarrays were performed on the whole blood samples of a cohort of 23 HD mutation carriers and 23 controls to identify differentially expressed (DE) transcripts.

View Article and Find Full Text PDF
Article Synopsis
  • - Amyotrophic lateral sclerosis (ALS) is a severe condition that affects motor neurons, leading to muscle wasting, and is associated with small RNA molecules, particularly microRNAs (miRNAs), which regulate gene expression in specific tissues like muscle.
  • - Researchers discovered that certain myomiRs are deregulated in ALS muscle tissue, and after conducting small RNA sequencing, they compared expressions between ALS patients and healthy individuals to identify potential therapeutic targets.
  • - The study found various small RNAs linked to insulin signaling and muscle repair processes, suggesting that the muscle tissue in ALS patients is actively attempting to compensate for damage, highlighting areas for future research and treatment development.
View Article and Find Full Text PDF

Amyotrophic lateral sclerosis and frontotemporal lobar degeneration are two ends of a phenotypic spectrum of disabling, relentlessly progressive and ultimately fatal diseases. A key characteristic of both conditions is the presence of TDP-43 (encoded by TARDBP) or FUS immunoreactive cytoplasmic inclusions in neuronal and glial cells. This cytoplasmic mislocalization of otherwise predominantly nuclear RNA binding proteins implies a perturbation of the nucleocytoplasmic shuttling as a possible event in the pathogenesis.

View Article and Find Full Text PDF

The G4C2 hexanucleotide repeat expansion mutation (HREM) in C9ORF72, represents the most common mutation associated with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Three main disease mechanisms have been proposed to date: C9ORF72 haploinsufficiency, RNA toxicity, and accumulation of dipeptide repeat proteins. Pure GC content of the HREM potentially enables the formation of various non-B DNA structures such as G-quadruplexes and i-motifs.

View Article and Find Full Text PDF

The G4C2 hexanucleotide repeat expansion, located in the first intron of the C9ORF72 gene, represents a major genetic hallmark of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Several hypotheses have been proposed on how the transcribed repeat RNA leads to the development of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. However, despite their importance, factors affecting the transcription of expanded-repeat RNA are not well known.

View Article and Find Full Text PDF
Article Synopsis
  • MicroRNAs (miRNAs) are short, noncoding RNAs that regulate gene expression in a broad and tissue-specific manner, with muscle-specific variants known as myomirs playing key roles in muscle function.
  • Myomirs are crucial for processes like muscle development, maintenance, and responses to factors such as exercise, but they're also linked to muscle atrophy caused by aging, inactivity, and various disorders.
  • Understanding how myomirs function and their expression dynamics is essential for exploring their potential as therapeutic targets for preventing muscle atrophy associated with chronic and infectious diseases.
View Article and Find Full Text PDF
Article Synopsis
  • ALS and FTLD are severe neurodegenerative diseases linked by dysfunctional RNA metabolism, characterized by the aggregation of RNA binding proteins.
  • The discovery of a hexanucleotide repeat expansion (GGGGCC) in the C9ORF72 gene is the most common genetic cause of both conditions and contributes to the pathology by disrupting RNA processes and forming toxic structures.
  • Understanding the mechanisms behind these diseases, including the role of key proteins like TDP-43, is crucial for developing potential treatments.
View Article and Find Full Text PDF

DNA from two novel HPV genotypes, HPV-150 and HPV-151, isolated from hair follicles of immuno-competent individuals, was fully cloned, sequenced and characterized. The complete genomes of HPV-150 and HPV-151 are 7,436-bp and 7,386-bp in length, respectively. Both contain genes for at least six proteins, namely E6, E7, E1, E2, L2, L1, as well as a non-coding upstream regulatory region located between the L1 and E6 genes: spanning 416-bp in HPV-150 (genomic positions 7,371 to 350) and 322-bp in HPV-151 (genomic positions 7,213 to 148).

View Article and Find Full Text PDF

Treatment of chronic hepatitis C is associated with varying success rates, substantial medical costs and serious side effects. Several host polymorphisms have been identified near the IL28B gene, of which the homozygous rs12979860 CC was found to be associated with significantly favourable treatment outcome. To determine accurately the presence of this variant, a real-time PCR assay with detection based on post-PCR high-resolution melting analysis (HRM) was developed.

View Article and Find Full Text PDF
Article Synopsis
  • The Abbott RealTime High Risk HPV test detects 14 high-risk HPV types and differentiates HPV-16 and HPV-18 in a single test aimed at cervical cancer screening.
  • The study evaluated the test's analytical specificity and clinical sensitivity compared to the Digene Hybrid Capture II Test (hc2) using archived cervical samples with confirmed cases of cervical carcinoma and CIN3 lesions.
  • Results showed high agreement between RealTime and hc2, with clinical sensitivity for cervical cancer at 88.4% (RealTime) versus 87.3% (hc2), and 91.8% (RealTime) versus 89.1% (hc2) for CIN3 lesions, indicating RealTime’s effectiveness in detecting high
View Article and Find Full Text PDF
Article Synopsis
  • A genotyping study analyzed 285 specimens using a low-risk probe cocktail and found cross-reactivity with various human papillomavirus (HPV) genotypes.
  • The cross-reactivity usually helped clinicians by identifying untargeted low-risk HPV types.
  • However, 8.4% of positive results were weak and linked to high-risk genotypes, suggesting the need for a "gray zone" in interpretations.
View Article and Find Full Text PDF